Zacks Research Issues Negative Outlook for Revvity Earnings

Revvity Inc. (NYSE:RVTY) – Investment analysts at Zacks Research lowered their Q2 2026 earnings per share estimates for shares of Revvity in a note issued to investors on Tuesday, May 26th. Zacks Research analyst Team now forecasts that the company will earn $1.26 per share for the quarter, down from their previous forecast of $1.31. The consensus estimate for Revvity’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Revvity’s Q4 2026 earnings at $1.70 EPS, Q1 2027 earnings at $1.26 EPS, Q3 2027 earnings at $1.48 EPS, Q4 2027 earnings at $1.74 EPS, FY2027 earnings at $5.95 EPS, Q1 2028 earnings at $1.45 EPS and FY2028 earnings at $6.89 EPS.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the prior year, the business earned $1.01 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS.

RVTY has been the subject of several other reports. The Goldman Sachs Group lowered their target price on Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a report on Tuesday, April 14th. Evercore upped their target price on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $117.00 target price on Revvity in a report on Wednesday, May 6th. Stifel Nicolaus decreased their price objective on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research note on Wednesday, May 6th. Finally, Jefferies Financial Group upped their price objective on Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Four investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $107.73.

Revvity Price Performance

Shares of RVTY stock opened at $96.69 on Wednesday. Revvity has a twelve month low of $81.22 and a twelve month high of $118.30. The stock has a market capitalization of $10.79 billion, a price-to-earnings ratio of 46.26, a P/E/G ratio of 2.09 and a beta of 1.05. The stock has a fifty day simple moving average of $91.16 and a two-hundred day simple moving average of $97.06. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio is currently 13.40%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. New York Life Investment Management LLC increased its position in Revvity by 72.7% during the 3rd quarter. New York Life Investment Management LLC now owns 27,520 shares of the company’s stock valued at $2,412,000 after buying an additional 11,583 shares in the last quarter. JPMorgan Chase & Co. increased its position in Revvity by 15.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock valued at $44,821,000 after buying an additional 67,662 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in Revvity during the 3rd quarter valued at about $15,128,000. First National Bank of Omaha acquired a new position in shares of Revvity in the third quarter valued at about $6,432,000. Finally, Elo Mutual Pension Insurance Co increased its holdings in shares of Revvity by 46.2% in the third quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock valued at $1,683,000 after purchasing an additional 6,066 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.